Teresa Bordoni

Title: Teresa Bordoni: Innovator in Antitumor Agents

Introduction

Teresa Bordoni is a prominent inventor based in Milan, Italy. She has made significant contributions to the field of pharmaceuticals, particularly in the development of antitumor agents. With a total of 2 patents, her work is recognized for its potential impact on cancer treatment.

Latest Patents

Among her latest patents, Bordoni has developed a new antitumor agent obtained by microbial stereoselective reduction of - 4'-Deoxy-13(S)-dihydro-4'-iododoxorubicin. This compound, along with its pharmaceutically acceptable salts, is noted for its effectiveness as an anti-tumor agent. Additionally, she has worked on antitumor anthracycline glycosides and their intermediates, which are described in her patents. These new compounds, characterized by specific chemical formulas, are also recognized for their utility as antitumor agents.

Career Highlights

Teresa Bordoni is currently employed at Farmitalia Carlo Erba S.p.a., where she continues her research and development efforts. Her work has been instrumental in advancing the understanding and application of antitumor therapies.

Collaborations

Throughout her career, Bordoni has collaborated with notable colleagues, including Alberto Bargiotti and Pierangelo Zini. These partnerships have contributed to her innovative research and the successful development of her patented compounds.

Conclusion

Teresa Bordoni's contributions to the field of antitumor agents highlight her role as a leading inventor in pharmaceutical innovation. Her work continues to pave the way for advancements in cancer treatment.